Tyra Biosciences, Inc. SEC filings TYRA

Tyra Biosciences, Inc. has 426 filings in SEC EDGAR's recent list, going back to May 28, 2021. Its latest annual report, Form ARS, was filed on Apr 17, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 4, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 15, 2026 (other events). The company's fiscal year ends on December 31.

Form Description Filed Period
DEFA14A Additional proxy material Apr 17, 2026 —
DEF 14A Proxy statement Apr 17, 2026 May 28, 2026
DEFA14A Additional proxy material Apr 18, 2025 —
DEF 14A Proxy statement Apr 18, 2025 May 29, 2025
DEFA14A Additional proxy material May 7, 2024 —
DEFA14A Additional proxy material Apr 18, 2024 —
DEF 14A Proxy statement Apr 18, 2024 May 29, 2024
PRE 14A Preliminary proxy statement Apr 5, 2024 May 29, 2024
DEFA14A Additional proxy material Apr 17, 2023 —
DEF 14A Proxy statement Apr 17, 2023 May 31, 2023
DEFA14A Additional proxy material Apr 28, 2022 —
DEF 14A Proxy statement Apr 28, 2022 Jun 13, 2022

Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
TYRA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Carlsbad, CA
SEC filer status
, Emerging growth company
SEC CIK
1863127

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.